IP Library Granted Patent US 9,023,091
Granted Patent B2
US 9,023,091 · App. 13/788,159 · Granted May 5, 2015

Treating cancer using electromagnetic fields in combination with photodynamic therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,023,091
App. No.
13/788,159
Granted
May 5, 2015
Kind
B2
Abstract

A light generating circuit is implanted in a subject's body and aimed at a target region such as a tumor. A photosensitizer is introduced into the target region, and an AC electric field is induced in the region. The field causes the light generating circuit to generate light, which activates the photosensitizer; and at certain field strengths and frequencies, the field itself has a beneficial effect. The beneficial effects of the field and the activated photosensitizer are thereby obtained simultaneously.

Claims (12)

1. An apparatus for simultaneously exposing a target region within a subject's body to light and an electric field, the subject's body having an internal resistance, the apparatus comprising:

at least two electrodes configured so that when the at least two electrodes are applied to a surface of the subject's body and driven by an AC voltage source, an AC electric field is capacitively coupled into the target region within the subject's body;

an AC waveform generator operatively connected to the at least two electrodes, the AC waveform generator having a frequency between about 50 kHz and about 500 kHz; and

a light-emitting assembly that is adapted for implantation within the subject's body, the light-emitting assembly having a first terminal and a second terminal, wherein the light-emitting assembly has a forward resistance that is significantly larger than the internal resistance of the subject's body, and wherein the light-emitting assembly is configured to emit light when the first terminal and the second terminal are positioned with respect to the AC electric field so that an AC voltage gradient of 2 V or more appears between the first terminal and the second terminal.

2. The apparatus of claim 1 , wherein the light-emitting assembly comprises a light-emitting diode.

3. The apparatus of claim 1 , wherein the first terminal and the second terminal are spaced apart by a distance of between 0.5 and 5 cm.

4. The apparatus of claim 1 , wherein a surface of the at least two electrodes that contacts the subject's body is insulated.

5. The apparatus of claim 1 , wherein the light-emitting assembly comprises a plurality of light-emitting diodes wired in parallel.

6. The apparatus of claim 1 , wherein the AC waveform generator has a frequency between 100 and 500 kHz.

7. The apparatus of claim 1 , wherein the AC electric field has an intensity between 1 and 10 V/cm in the target region.

8. The apparatus of claim 7 , wherein the first terminal and the second terminal are spaced apart by a distance of 2 cm or more.

9. The apparatus of claim 1 , wherein the first terminal and the second terminal are spaced apart by a distance of 2 cm or more.

Assignments (16)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
CHANGE OF NAME Recorded Dec 29, 2014
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 034594/0061 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2014
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 034531/0445 →